Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. (2023)
Attributed to:
High Dose Oral Rifampicin to Improve Survival from Adult TB Meningitis - (HARVEST) Trial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-44152-8
PubMed Identifier: 38110410
Publication URI: http://europepmc.org/abstract/MED/38110410
Type: Journal Article/Review
Volume: 14
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723